EMA publishes EPAR for Aerivio Spiromax

5 September 2016 - The EMA has published an EPAR for Teva Pharmaceuticals' version of GSK's Seretide/Advair.

The European Commission approved Aerivio Spiromax on 18 August 2016 for use by certain patients with asthma or chronic obstructive pulmonary disease.

Read EPAR for Aerivio Spiromax

Michael Wonder

Posted by:

Michael Wonder